The aim of present work is to prepare the orally dissolving tablets of poorly soluble Ondransetron Hydrochloride as its soluble form by adopting complexation method using different superdisintegrants alone and in combination. The growing importance of orally dissolving tablet was underlined recently when European Pharmacopoeia adopted the term “Oro dispersible tablet” as a tablet that to be placed in the mouth where it disperses rapidly before swallowing. Their characteristic advantages such as administration without water anywhere, anytime lead to their suitability to geriatric and paediatric patients. The complex prepared was showed better solubility in simulated salivary PH of 6.8. The pre compression characteristics of drug, drug with Beta cyclodextrin and final blend were evaluated with respect to standards. Results of the study showed that the optimized tablet with combination of superdisintegrants (2.5% crosspovidone, 3.5% sodium starch glycolate) showed hardness of 3.5Kg/Cm2, thickness 2.10mm, wetting time 18 sec, drug content 99.15%, disintegration time 20sec, in-vitro dispersion time 25sec, in-vitro drug release of 89.59% (in 3min) and percentage of drug permeation as 89.45% (in 5 min) and it is comparable with higher percentage of superdisintegrants used for tablet preparation. So this method was a promising approach for developing cost effective dosage form with high efficacy in treatment.
Cite this article:
Beena P, Arun G Krishnan, Nisha Ullas, Chippy S Pillai, Sam C Mathew, Salikh Salim. Development and Characterization of Orally Dissolving Tablet of a Poorly Soluble Antiemetic Drug. Research Journal of Pharmacy and Technology. 2021; 14(4):2172-8. doi: 10.52711/0974-360X.2021.00384
Beena P, Arun G Krishnan, Nisha Ullas, Chippy S Pillai, Sam C Mathew, Salikh Salim. Development and Characterization of Orally Dissolving Tablet of a Poorly Soluble Antiemetic Drug. Research Journal of Pharmacy and Technology. 2021; 14(4):2172-8. doi: 10.52711/0974-360X.2021.00384 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-4-60
1. Chien YW. Novel drug delivery systems.2nd edition. New York. Marcel DekkerInc; 1992.
2. Indurwade NH, Rajyaguru TH, Nakhat PD. Novel Approach-Fast Dissolving Tablets. Indian Drugs. 2002; 39(8): 405-9.
3. Watanabe Y, Koizumi K, Zama Y, Matsumoto Y, Motsumoto M. New compressed tablet: rapidly disintegrating in saliva in the mouth using crystalline cellulose and a Disintegrant. Bio Pharm. Bull 1995; 18(9): 1308-10.
4. Yonezawa BY, Sunanda H. Rapidly disintegrating tablets prepared by the wet compression method: Mechanism and optimization. J. Pharm. Sci. 1999;88(1): 1004-10.
5. Debjit Bhowmik, Chiranjib. B, Krishnakanth, Pankaj, R. Margret Chandira. Fast Dissolving Tablet: An Overview Journal of Chemical and Pharmaceutical Research.2009; 1(1): 163-177.
6. Jigar V soni, Nirav R. Patel, Dr. Praful D. Bharadia, Vikram M. Pandya, Darshan M. Modi. Different Methods and Evaluation Parameters of Fast Disintigrating Tablets. IJPI’s Journal of Pharmaceutics and Cosmetology.2011; (1): 4.
7. Siraj Shaikh, V. Khirsagara, Aamer Quazi. Fast Disintegrating Tablets: An Overview of Formulation and Technology. International Journal of Pharmacy and Pharma Science.2010; 2(3): 9-15.
8. K. Koizumi. New Method of Preparing Highly Porous Rapidly saliva Soluble Tablets by Sublimation. International Journal of Pharmacy.1997; 127-31.
9. Allen LV, Wang B. Process for making a particulate support matrix for making a rapidly dissolving dosage form.US Patent.2001; 6,207, 199.
10. S. Corveleyn J. P. Remon. Formulation and Production of rapidly disintegrating tablets by Lyophilization Technique. International Journal of Pharmacy.1997; 215-217.
11. Heinemann H, Rothe W. Preparation of porous tablets. US Patent 3,885,026. 1975.
12. Shimizu, Y. Nakano, S. Morimoto, T. Tabata, N. Hamaguchi and Y. Igari, Chem. Pharm. Bull. 2003; 942–947, 1029-1035.
13. Lafon L. Galenic form for oral administration and its method of preparation by lyophilization of an oil-in-water emulsion. US Patent: 1986; 4,616, 047.
14. Gole DJ, Levinson RS, Carbone J, Davies JD. Preparation of Pharmaceutical and other matrix systems by solid-state dissolution. US Patent; 1993: 5, 215, and 756.
15. Wehling F, Schuehle S. Base coated acid particles and effervescent formulation incorporating same. US Patent; 1996: 5, 503, 846.
16. Wehling F, Schuehle S, Madamala N. Efferrvescent dosage form with Micro Particles. US Patent; 1993: 5, 178, 878.
17. Amborn J, Tiger V. Apparatus for handling and packaging Friable Tablets. US Patent; 2001: 6, 311, 462.
18. Mizumoto T, Masuda Y, Fukui M. Intra-buccally dissolving compressed Mouldings and production process thereof. US Patent; 1996:5, 576, 014.
19. Mizumoto T, Masuda Y, Kajiyama A, Yanagisawa M, Nyshadham JR. Tablets quickly disintegrating in the oral cavity and process for producing the same. US Patent; 2003: 6, 589, 554.
20. Cousin G, Bruna E, Gendrot E. Rapidly disintegratable multi particular tablet. US Patent; 1995: 5, 464, 632.
21. Ramesh Kannuri, Threveen Challa, Haeesha Chamarthi. Taste masking and evaluation method for Oro dispersible Tablets. Int.J. Pharma and Ind.Res.2011: 200 210.
22. Rajeswari C, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: An updated review. AAPS Pharm Sci Tech. 2005 Jan; E1-102.
23. Rao BP, Suresh S, Narendra C. Recent advances in cyclodextrin complexes: Mechanistic analysis as permeation enhancer. Indian Journal of Pharm Edu Res 2007 Apr-Jun; 41(2): 102-113.
24. Marcus E, Brewster, Thorsteinn Loftsson. Cyclodextrins as pharmaceutical Solubilizers. Advance drug delivery reviews; 59 (2007): 645-666.
25. GarimYadav, Anupriya Kapoor, Shilpi Bhargava. Fast Dissolving Tablets Recent Advantages: A Review. International Juornal of Pharmaceutical Science and Research.2012; 3: 728-736.
26. Radha Bhati, Raja K Nagrajan. A Detailed Review on Oral Mucosal Drug Delivery System. International Journal of Pharmaceutical Science and Research.2012; 3: 659-681.
27. Chowdary, Aishwarya. Recent Research on Fast Dissolving Tablets- A Review. Journal of Global Trends in Pharmaceutical Sciences.2013; 4: 94-954.